Year: 2012
Type: article
Abstract: Arsenic trioxide (ATO) is highly effective in patients with relapsed or refractory acute promyelocytic leukemia (APL) [1]. ATO as a first-line agent in induction and consolidation, either alone or ...
Authors: Eytan M. Stein, Martin S. Tallman
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2154737974